Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model

Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model

The Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in 2012 and causes severe and often fatal acute respiratory illness in humans. No approved prophylactic and therapeutic interventions are currently available. In this study, we have developed egg yolk antibodies (immunoglobul...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Aymn T. Abbas, Sherif A. El-Kafrawy, Sayed Sartaj Sohrab, Ashraf A. Tabll, Ahmed M. Hassan, Naoko Iwata-Yoshikawa, Noriyo Nagata, Esam I. Azhar
Format: Artykuł
Język:English
Wydane: MDPI AG 2020-11-01
Seria:Vaccines
Hasła przedmiotowe:
MERS-COV
egg yolk antibodies
IgY against MERS-COV
vaccine
passive immunotherapy
controlling of MERS-COV infection
Dostęp online:https://www.mdpi.com/2076-393X/8/4/634

Internet

https://www.mdpi.com/2076-393X/8/4/634

Podobne zapisy